“…Low molecular weight spirulina peptides (0-3 kDa) have been shown to have strong antioxidant activity as well as a variety of potentially bene cial health effects. These include its anti-cancer effects, blood cholesterol and blood pressure reduction, and probiotic effects with relatively high digestibility and low allergenicity (Ma et al, 2021;Mohammadi et al, 2023) Although bioactive peptides have been shown to have numerous bene ts, low bioavailability, hydrophobicity, instability, incompatibility, and bitterness affect its functions and pharmaceutical applications (Bourbon et al, 2019;Gomes and Sobral, 2021).Nanocarrier-based drug delivery methods are considered a promising strategy to protect bioactivity, enable controlled release of bioactive peptides, and overcome the systemic toxicity of conventional drugs (Guha and Majumder, 2019;Hosseini et al, 2017;Ilk et al, 2017). The ability of liposomes to encapsulate hydrophobic, hydrophilic, and amphiphilic compounds makes them ideal carriers for drugs and bioactive substances(Giri et al, 2015; Kharat and McClements, 2019).…”